CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Biofrontera Inc.

BFRI
$17MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for BFRI. That does not mean none is planned.

Get an email about BFRI's next catalysts

Track Biofrontera (BFRI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaWOBURN
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Biofrontera Inc.'s drug pipeline?β†’

CatalystAlert tracks 4 drug candidates in Biofrontera Inc.'s (BFRI) pipeline across Phase 3. Its lead program is BF-200 ALA (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Biofrontera Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Biofrontera Inc. (BFRI) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track BFRI biotech catalysts?β†’

Add BFRI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Biofrontera Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply